Piotr is a Global Head in Regulatory Affairs for smoke-free products (SFPs) at PMI. He joined PMI in 2017 as a Regional Head Regulatory & Scientific Affairs for the EU region. Piotr is a trained pharmacist and graduated from the Medical University of Warsaw in Poland.
In his current role, Piotr leads a team responsible for the development of strategies for regulatory submissions and authorizations of SFPs. In doing so, he and his team provide expertise and guidance on regulatory matters throughout the lifecycle of SFPs, from early development and market access to post-market activities. As a pharmacist, Piotr is a believer and keen advocate of tobacco harm reduction strategies and supports PMI’s ambition to deliver a smoke-free future.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.